Trials / Completed
CompletedNCT04672538
Fontan Physiology Ventilation Strategy
Impact of Fontan Ventilation Strategy on Cardiac Output: An Invasive Physiologic Cross-over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will investigate the different tidal volume (Vt) strategies during a cardiac catheterization procedure to determine whether or not low or high Vt have an impact on cardiac output. Research question: While maintaining the same minute ventilation/PaCO2, does higher Vt (10 cc/kg)/lower rate vs. lower Vt (6 cc/kg)/higher rate (maintaining consistent PEEP) result in improved cardiac output?
Detailed description
The trial will be a randomized crossover design. The study cohort will be randomized (50/50) to begin with either low Vt or high Vt ventilation. After achieving steady state, initial cardiac output measurements will be made using a measured oxygen consumption (VO2) and the Fick principle, per routine clinical protocol. Following baseline assessment of cardiac output and hemodynamics (which is standard of care for all catheterization procedures), participants will be transitioned to the alternative ventilation modality (high Vt or low Vt). After a 5-minute equilibration period, oxygen saturations and VO2 measurements will be re-acquired, to determine cardiac output and hemodynamics in this second state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Low Vt protocol | Low Vt protocol - tidal volumes (Vt) 6 ml/kg, respiratory rate required for end tidal carbon dioxide (EtCO2) of 36-38 mmHg, PEEP 5 centimeter of water (cm-H20) , I:E ratio 1:2 |
| PROCEDURE | High Vt protocol | High Vt protocol - tidal volumes (Vt) 10 ml/kg, respiratory rate required for EtCO2 of 36-38 mm Hg, PEEP 5 cmH2O, I:E ratio 1:3. |
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2023-03-14
- Completion
- 2023-05-15
- First posted
- 2020-12-17
- Last updated
- 2023-05-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04672538. Inclusion in this directory is not an endorsement.